Assessment the effect of Carvedilol in preventing Heart failure in breast cancer patients.
Phase 3
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT2017042433619N1
- Lead Sponsor
- Vice chancellor for research of Baqiyatallah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
breast cancer patients under treatment with herceptin or antracyclines.
Exclusion criteria: EF less than50%; Significant Valvular Heart Disease; GFR<30ml/h/m2; Hepatic Failure; Contraindications for beta blockers; Symptoms of Heart Failure.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft and Right Ventricule Function. Timepoint: 3 months after treatment. Method of measurement: Speckle Tracking Echocardiography.
- Secondary Outcome Measures
Name Time Method